dm+d
419143009
Articles
Using NSAIDS during breastfeeding
2 February 2024
NSAIDs monitoring
22 June 2021
Medicine Compliance Aid Stability
Diclomax Retard
Galen Ltd
Galen Ltd
Diclomax Retard
Capsules 100mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Store in airtight container. Protect from moisture.
3 April 2022
generic
Dexcel Pharma Ltd
Dexcel Pharma Ltd
generic
Tablets gastro-resistant 25mg, 50mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
12 May 2022
Voltarol Rapid
Novartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Voltarol Rapid
Tablets 50mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture
12 May 2022
generic
Teva UK Ltd
Teva UK Ltd
generic
Tablets gastro-resistant 50mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture. Airtight container.
12 May 2022
generic
Sandoz Ltd
Sandoz Ltd
generic
Tablets enteric-coated 25mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture. Airtight container.
12 May 2022
Motifene
Daiichi Sankyo UK Ltd
Daiichi Sankyo UK Ltd
Motifene
Capsules 75mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Airtight container.
3 April 2022
Diclomax SR
Galen Ltd
Galen Ltd
Diclomax SR
Capsules 75mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Store in airtight container. Protect from moisture.
3 April 2022
Rhumalgan XL
Sandoz Ltd
Sandoz Ltd
Rhumalgan XL
Capsules modified release 100mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Airtight container.
12 May 2022
Rhumalgan CR
Sandoz Ltd
Sandoz Ltd
Rhumalgan CR
Capsules 75mg, 100mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from light. Protect from moisture. Airtight container.
12 May 2022
Lactation Safety Information
For oral/ rectal/ parenteral use
For oral/ rectal/ parenteral use
Extensive experience of safe use in breastfeeding
Limited published evidence of safety
No adverse effects reported in breastfed infants
Small amounts in breast milk
29 July 2020
Topical
Topical
Negligible milk levels anticipated as systemic absorption from topical formulations is low
Follow normal precautions for topical medicines (see summary)
29 July 2020
For ophthalmic use
For ophthalmic use
29 July 2020
For actinic keratitis
For actinic keratitis
Negligible milk levels anticipated as systemic absorption from topical formulations is low
Avoid contact of the breastfeeding infant with treated areas
30 October 2020